Ashok Kumar Das, Rakesh Kumar Sahay, Manash Pratim Baruah, Mangesh Tiwaskar, Sambit Das, Sudip Chatterjee, Banshi Saboo, Ganapathi Bantwal, Saptarshi Bhattacharya, Gagan Priya, Manoj Chawla, Kiraninder Brar, Syed Abbas Raza, Azizul Hasan Aamir, Dina Shrestha, Noel Somasundaram, Prasad Katulanda, Faria Afsana, Shahjada Selim, Mohammad Wali Naseri, Ali Latheef and Manilka Sumanatilleke have nothing to disclose
1 Comparison between GLP-1 RA and the GLP-1/GIP dual agonist (tirzepatide)
There is no published, peer-reviewed, full-paper randomised human trial with accessible results showing that BPC-157 is effective or safe for any indication
The most common complaints are nausea, vomiting, diarrhea, abdominal pain, constipation, heartburn and burping, as stated on the MedlinePlus website
Iron and iron-related proteins in COVID-19
31 A safety review of this study also identified a potential signal for increased cancer incidence, however, the study was not powered for cancer end-points